Fig. 6From: Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021FDA-approved therapeutic drugs for prostate cancers. a Distribution of therapeutic drugs for prostate cancers during the past 31 years (adapted from [423]). b AR antagonists. c GnRH agonist. d GnRH receptor antagonists. e Microtubule inhibitor. f CYP17A1 inhibitor. g α-particle-emitting radiopharmaceuticalBack to article page